Center for Molecular Imaging – VCU Supports Research Virginia-wide
Dr. Jamal Zweit, Director for the Molecular Imaging Center writes- About the Center for Molecular Imaging at VCU: The Center for Molecular Imaging (CMI) at VCU conducts multidisciplinary molecular imaging research using non-invasive imaging technologies. The...
Virginia Tech Center for Drug Discovery Researcher receives $1.2 million to find Compounds to Treat Fatty Liver Disease
Webster Santos (VT), Kyle Hoehn (UVA): A grant from the VBHRC, known as Virginia Catalyst along with matching funds from Continuum Biosciences, a company they co-founded will fund research to fight a liver condition that can lead to liver cancer. Read more ...
Frank Gupton receives a $25M award from the Gates foundation
Frank Gupton receives a $25M award from the Gates foundation for the "Medicines for All" Initiative" The Bill & Melinda Gates Foundation has awarded the Virginia Commonwealth University School of Engineering $25 million to create the Medicines for All Institute, a...
VirginiaCancerRx in the News!
John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...
Award-winning “intrapreneur” researcher Rob Gourdie launches Acomhal Research Inc.
Professor Rob Gourdie, Director of the Virginia Tech Carilion Research Institute’s (VTCRI) Center for Heart and Regenerative Medicine Research, previously founded First String Research Inc., which is poised to commercialize a treatment for debilitating foot ulcers in...
Carlier & Slade receive grant to develop new malaria therapeutics
A team headed by Paul Carlier, Professor of Chemistry, Virginia Tech has received funding from the National Institutes of Health to carry out lead optimization on antimalarial drug candidate MMV008138. Carlier, who is Deputy Director of the Virginia Tech Center for...
Inova Names Milton L. Brown, MD, PhD, Director of the New Inova Center for Drug Discovery and Development and Targeted Therapeutics
Milton L. Brown, MD, PhD, has recently joined Inova. He will serve as director of the new Inova Center for Drug Discovery and Development and as deputy director for Drug Discovery for the Inova Schar Cancer Institute (ISCI). Dr. Brown is a physician scientist who has...
Targeted Nanoparticle Delivery of Paclitaxel
Virginia Tech scientists have developed a cancer drug that increases the effectiveness of a common chemotherapy treatment and dramatically reduces devastating side effects, such as hair loss, nausea, and nerve pain. The new drug uses gold nanoparticles created by the...
Santos & Lynch developing SphK inhibitors
A drug discovery team headed by Webster Santos, Associate professor of Chemistry and member of the Virginia Tech Center for Drug Discovery, and Kevin Lynch, Professor of Pharmacology at the University of Virginia, School of Medicine, is developing inhibitors of...
Potential drug therapy for radiation exposure
Potential new treatments for radiation exposure: The investigators exploited an optimized, cell-based,high throughput screening assay to interrogate a small molecule library comprising 3437 known pharmacologically active compounds for mitigation against IR-induced...